GENPREX INC (GNPX)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$3.50+2.04%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · GNPX
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||
| Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 |
| Total Revenues | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 |
| Operating Expenses & Income | ||||||||||
| R&D Expenses | 9.8 | 9.4 | 10.5 | 17.6 | 11.5 | 9.0 | 7.3 | 2.0 | 1.0 | 0.3 |
| Operating Income | (15.8) | (15.5) | (21.2) | (31.1) | (23.8) | (20.7) | (18.0) | (10.7) | (12.4) | (3.3) |
| Earnings from Continuing Operations | ||||||||||
| Interest Expense | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Interest & Investment Income | — | — | 0.1 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Interest Expenses | — | — | — | — | — | — | — | 0.0 | 0.0 | 0.0 |
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | (0.0) | (0.0) |
| Income Tax Expense | — | — | 0.0 | 0.0 | 0.0 | — | — | — | — | — |
| Net Income | ||||||||||
| Net Income | (16.5) | (16.2) | (21.1) | (30.9) | (23.7) | (20.7) | (17.9) | (10.7) | (12.4) | (3.3) |
| Per Share | ||||||||||
| Basic EPS | (34.87) | (17.40) | (5.34) | (22.56) | (19.80) | (0.44) | — | — | — | — |
| Basic Weighted Avg Shares | 0.5 | 0.9 | 4.0 | 1.4 | 1.2 | 47.1 | — | — | — | — |
| Supplemental | ||||||||||
| EBIT | (15.8) | (15.5) | (21.2) | (31.1) | (23.8) | (20.7) | (18.0) | (10.7) | (12.4) | (3.3) |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.